Women at Higher Cardiovascular Risk Want Prevention Tools That Feel Personal, Not Generic
Women who were already living with cardiovascular risk factors described prevention in sharply different ways, and those differences shaped how they viewed digital health support in primary care. In interviews conducted with women over 40 in Quebec, the conversation was less about novelty than about whether a tool could fit the realities of daily life, family responsibilities, and the often invisible nature of cardiovascular disease before symptoms appear. The study used a qualitative descriptive design, which was well suited to a question that depends on lived experience rather than laboratory endpoints.
One striking theme ran through the interviews: many participants did not describe cardiovascular disease as a chronic process that develops over years. Some understood it as a distant event, while others associated it mainly with emergencies, chest pain, or the final stages of illness. That gap matters because primary prevention depends on risk recognition long before the first clinical event. When a condition is viewed only through the lens of acute crisis, the motivation to monitor blood pressure, cholesterol, diet, activity, or stress is easy to lose in the noise of everyday life.
Women also described obstacles that were social as much as medical. Competing demands, limited time, and the practical burden of making lifestyle changes emerged repeatedly as barriers to prevention. These are not abstract concerns; they shape whether a patient can consistently act on advice from a clinic visit or through an app. A prevention strategy that assumes uninterrupted attention and spare time will miss the reality of many women balancing work, caregiving, and their own health needs.
Prevention Often Begins With Confusion About Risk, Not Refusal of Care
The interviews suggest that a major limitation in cardiovascular prevention is not denial, but incomplete understanding. Participants described the disease in varied and sometimes fragmented ways, which points to a knowledge gap about its chronic course and broad manifestations. In practical terms, that means some women may not connect everyday risk factors with future vascular events until the risk has already advanced.
This is where primary care remains central. Preventive counseling in the office can identify risk factors, but digital support may extend that conversation into the days and weeks when decisions are actually made. The women in this study did not reject that idea. They wanted help that was concrete, responsive, and easy to interpret. Broad advice alone was less persuasive than support that could translate risk into clear, individualized action.
A second theme was agency. Several participants described taking charge of their cardiovascular well-being, showing that women are not passive recipients of prevention messages. They were already making choices about food, movement, medication, and self-monitoring. The real question was whether a digital tool could reinforce those efforts without becoming burdensome or impersonal.
AI-Enabled Prevention Tools Drew Interest, but Also Caution
The most interesting part of the study was the mixed reaction to artificial intelligence-enabled technologies for cardiovascular prevention, including the proposed Xi-Care platform. Some women saw potential in customization, interaction, and reminders that could adapt to individual needs. Others were more guarded, especially when technology felt too abstract, too complicated, or insufficiently trustworthy. Those reactions are clinically important because uptake depends on perceived usefulness and credibility, not on technical sophistication alone.
A digital intervention that recommends behavior change must earn attention quickly. If it repeats generic advice, it risks being ignored. If it feels intrusive or difficult to navigate, it may never move beyond first use. The women in this study were effectively asking for a tool that behaves more like a skilled coach than a static checklist: responsive to context, tailored to risk, and respectful of the user’s pace.
One participant insight appears especially relevant for developers of preventive platforms. Customization was not treated as a luxury feature. It was part of whether a tool would be usable at all. Women wanted format and design choices that matched how they already manage health information, whether through brief prompts, visual layouts, or interactive support. In a prevention setting, interface design can determine whether risk communication becomes actionable or simply adds to the burden of managing another screen.
Design Preferences Point Toward a More Human Digital Tool
The study’s fifth theme moved from attitudes to implementation. Participants offered suggestions for how a prospective AI-enabled intervention should look and behave, which gives developers a rare window into the expectations of end users before deployment. The message was straightforward: design matters when the target population is being asked to engage with prevention over time.
A prevention platform for women at increased cardiovascular risk will need to do several things at once. It must present information clearly, avoid overwhelm, adapt to user needs, and maintain a tone that feels supportive rather than corrective. Those goals align with the logic of digital prevention in primary care, where repeated contact can help sustain behavior change between office visits. In that context, AI is not the endpoint; it is the mechanism that may allow personalization at scale.
The findings also point to a broader systems issue. Women’s cardiovascular risk is often underrecognized, and preventive tools can only be effective if they are built around the way patients understand illness in the first place. If a platform assumes a baseline level of knowledge that many users do not have, it will start at a disadvantage. If it fails to address daily constraints, it will lose relevance quickly.
A Small Qualitative Sample Still Reveals Where Prevention Breaks Down
Fifteen interviews cannot define the experience of all women at cardiovascular risk, and this cohort came from a McGill University-affiliated clinic in Quebec with English-speaking participants over 40 years old. Those boundaries limit how far the findings can be generalized. Even so, qualitative research is designed to surface patterns that large surveys often flatten, and the themes here are clinically coherent.
The most actionable insight is simple: women want cardiovascular prevention tools that help them understand risk, fit into their routines, and respond to their individual circumstances. Mixed enthusiasm for AI does not signal rejection. It signals a demand for better design, clearer purpose, and a tool that earns trust through usefulness rather than branding.
For the Xi-Care project, the interviews provide a directional map. The next phase will need to convert these preferences into a platform that is understandable, interactive, and genuinely tailored to women trying to prevent disease before it becomes visible.